Herbridge, 25 Feb.2010_As a precious traditional medicinal material, rhodiola rosea wildly grows in China. The over-exploitation year by year brought great chanllenges to the rhodiola rosea extract market this year.
According to herbridge.com, the new crop arrival last fall didn't bring hope to domestic manufacturers. The crops' doubled prices forced several manufacturers to stop production. For years, rhodiola rosea extract has seen moderate and stable demand from domestic and overseas market, as is also contributed to manufacturers' decision of stopping prodution.
There are only a few manufacturers to supply rhodiola rosea extract and fewer manufacturers capable of receiving new orders in China. 3% salidroside is almost unavailable now in the market, while the specification is very popular in previous years. There is about 1 ton of 1% salidroside left for sale in the market. The prices for 3% and 1% salidroside are approximately 220RMB/kg (which was 140RMB/kg in H1 2010) and 65RMB/kg, respectively. Currently, the market is comparatively stable in China.
Copyright: www.herbridge.com
- White Paper on Bone and Joint Health of Chinese Consumers 2020
- Yili Dairy launched high-protein yogurt, focusing on sport people
- Sinopharm Xingsha launched the Japan's Champion probiotics
- China has introduced its first policy to support the industrial hemp industry
- Beyond Meat became the first overseas Artificial Meat company to set up a factory in China
- Nongfu Spring's market value exceeded HK $370 billion on its first day
- German infant nutrition brand Amykon launched two probiotics in China
- The revenue of Besunyoung in the first half year is about 610 million yuan
- Jellly candy and powder included in the health food filing dosage form in China
- H&H Group net profit increased by 9% for the first half of year
